Methotrexate on a 21-Day Cycle for Low-Risk Gestational Trophoblastic Neoplasia
Published In/Presented At
Diaz J; Thomas MB; Paz-Pabon C; Hernandez, E. (2012). Methotrexate on a 21-day cycle for low-risk gestational trophoblastic neoplasia. The Journal Of Reproductive Medicine, 57(9-10), 411-414.
Medical Specialties | Medicine and Health Sciences | Obstetrics and Gynecology
Department of Obstetrics and Gynecology, Department of Obstetrics and Gynecology Faculty